From: Expression of tumor pyruvate kinase M2 isoform in plasma and stool of patients with colorectal cancer or adenomatous polyps
Sample type
Lesion type
Suggested cut-off value based on ROC (U/ml)
Sensitivity
Specificity
AUC
Stool
Tumor
> 8
100%
85.6%
0.969
Polyp
> 4.8
81.6%
74.8%
0.834
Plasma
> 25
90.9%
91.3%
0.975
> 19
96.3%
85.5%
0.95